Metastatic Disease Clinical Trial
Official title:
Open-label, Uncontrolled, Multicenter Phase I/Ib Trial to Investigate Safety and Efficacy of BIBW 2992 and Standard Gemcitabine/Cisplatin in Chemo-naïve Patients With Advanced Biliary Tract Adenocarcinoma
An open-label, uncontrolled, multicenter phase I/Ib trial to investigate safety and efficacy of BIBW 2992 added to the standard therapy of Gemcitabine/Cisplatin in chemo-naïve patients with advanced and/or metastatic adenocarcinoma of the biliary tract
The primary objective is safety and toxicity, including maximum tolerated dose, of BIBW 2992 when given as add-on therapy to Gem/Cis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01450683 -
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
|
Phase 2 | |
| Terminated |
NCT04116164 -
Safety and Targeting of Anti-hk2 Antibody in mCRPC
|
Early Phase 1 | |
| Completed |
NCT04595032 -
MAnagement of METastatic Disease In Campania (MAMETIC)
|
||
| Terminated |
NCT01020305 -
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT02496832 -
A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo
|
N/A | |
| Completed |
NCT01763970 -
Stereotactic Radiation Therapy for Pediatric Sarcomas
|
N/A | |
| Completed |
NCT01703910 -
Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic
|
Phase 2 | |
| Completed |
NCT00609401 -
Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)
|
Phase 2 | |
| Completed |
NCT02628379 -
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
|
||
| Completed |
NCT00480389 -
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal
|
Phase 2 | |
| Recruiting |
NCT03632005 -
Negative Pressure Wound Therapy vs. Sterile Dressing for Patients Undergoing Thoracolumbar Spine Surgery
|
N/A | |
| Recruiting |
NCT04492735 -
The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies
|
||
| Terminated |
NCT02175654 -
Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
|
Phase 2 | |
| Completed |
NCT01875380 -
Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT01861938 -
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
|
Phase 2/Phase 3 | |
| Terminated |
NCT00532454 -
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
|
Phase 2 | |
| Terminated |
NCT02795819 -
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
|
Phase 1 | |
| Recruiting |
NCT05188911 -
Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial
|
||
| Completed |
NCT03823989 -
Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients
|
Phase 1 | |
| Terminated |
NCT01904916 -
CPCT-05 Biopsy Protocol Patient Selection
|
N/A |